Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells

Molecular Pharmacology

Volumn 60, Issue 6, 2001, Pages 1268-1279

  Schwartz, P S ^a   Waxman, D J ^a  

^a Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROPEROXYIFOSFAMIDE; CASPASE 3; CASPASE 7; CASPASE 9; CYCLOPHOSPHAMIDE; IFOSFAMIDE; LIPOCORTIN 5; MAFOSFAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL MEMBRANE; CONTROLLED STUDY; CYTOSTASIS; DRUG ACTIVATION; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME DEGRADATION; GENE THERAPY; GLIOSARCOMA; MEMBRANE PERMEABILITY; MITOCHONDRION; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL DESTRUCTION; TUMOR CELL LINE;

EID: 0035210529     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.60.6.1268     Document Type: Article

References (53)

1. The Bcl-2 protein family: Arbiters of cell survival
2. Death receptors: Signaling and modulation
3. Cell death beyond apoptosis
4. Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein
5. Effect of combined treatment with interleukin-3 and interleukin-6 on 4- hydroperoxycyclo-phosphamide-induced programmed cell death or apoptosis in human myeloid leukemia cells
6. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
7. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification
8. Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: Development of a combined chemotherapy/cancer gene therapy strategy
9. The apoptesome: Heart and soul of the cell death machine
10. Cell-cycle disruptions and apoptosis induced by the cyclophosphamide derivative mafosfamide
11. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis
12. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
13. bcl-2 modulation of apoptosis induced by anticancer drugs: Resistance to thymidylate stress is independent of classical resistance pathways
14. Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells
15. Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy
16. Apoptotic pathways: The roads to ruin
17. Mitochondria and apoptosis
18. Fluorometric and colorimetric detection of caspase activity associated with apoptosis
19. Construction of P450-expressing tumor cell lines using retroviruses
20. Induction of DNA crosslinks and DNA strand lesions by cyclophosphamide after activation by cytochrome P450 2B1
21. Retroviral transfer of human cytochrome P450 genes for oxazaphosphorine- based cancer gene therapy
22. Frequent, moderate-dose cyclophosphamide administration improves the efficacy of P450 reductase-based cancer gene therapy
23. bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair
24. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
25. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer
26. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs
27. Cytochrome c release from mitochondria of early postimplantation murine embryos exposed to 4-hydroperoxycyclophosphamide, heat shock, and staurosporine
28. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
29. Clinical pharmacokinetics of cyclophosphamide
30. Caspases: The proteases of the apoptotic pathway
31. Production of high-titer helper-free retroviruses by transient transfection
32. Modulation of Bcl-2 protein levels by an intracellular anti-Bcl-2 single-chain antibody increases drug-induced cytotoxicity in the breast cancer cell line MCF-7
33. Bcl-2 family proteins
34. Bcl-2 family proteins: Relative importance as determinants of chemoresistance in cancer
35. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: Comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides
36. Localization of the Bcl-2 protein to the outer mitochondrial membrane by electron microscopy
37. Caspase-9 and APAF-1 form an active holoenzyme
38. Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P- 450 profiles
39. Two CD95 (APO-1/Fas) signaling pathways
40. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells
41. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma
42. Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner
43. Bcl-2 expression correlates with apoptosis induction but not tumor growth delay in transplantable murine lymphomas treated with different chemotherapy drugs
44. The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy
45. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis
46. Mitochondrial release of caspase-2 and -9 during the apoptotic process
47. Substrate specificities of caspase family proteases
48. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis
49. Cytochrome P450-based cancer gene therapy: Recent advances and future prospects
50. Movement of Bax from the cytosol to mitochondria during apoptosis
51. Apaf1 is required for mitochondrial pathways of apoptosis and brain development
52. P450 enzyme expression patterns in the NCI human tumor cell line panel
53. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence